AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Change in Accured Expenses of -$4.1 million for Q1 2026, down 194.27% year-over-year from $4.4 million in Q1 2025, and down 194.27% quarter-over-quarter from -$1.4 million in Q1 2025.

Analysis

AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026) Analysis & Trends

AtaiBeckley has reported Change in Accured Expenses for 6 years, with the latest figure at -$3.6 million in Q3 2025.

  • Quarterly Change in Accured Expenses fell 167.62% year-over-year to -$3.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$2.1 million (up 4.54% YoY) and the FY2024 annual result came in at -$6.2 million, down 87.18% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$4.1 million, down from -$1.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was -$1.4 million in Q1 2025, with the low at -$4.1 million in Q1 2026.
  • A 5-year average of -$119052.6 and a median of -$270000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses surged 6546.73% in 2021, then slumped 404.44% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $2.5 million in 2021, then slumped by 248.71% to -$3.7 million in 2022, then soared by 144.5% to $1.6 million in 2023, then slumped by 246.24% to -$2.4 million in 2024, then tumbled by 51.24% to -$3.6 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.6 million, $5.7 million, and -$1.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn - -3.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.99 Mn
Mar 31, 2026 -4.11 Mn
Sep 30, 2025 -3.65 Mn
Jun 30, 2025 5.68 Mn
Jun 30, 2025 5.71 Mn
Mar 31, 2025 -1.71 Mn
Mar 31, 2025 -1.40 Mn
Dec 31, 2024 -2.41 Mn
Sep 30, 2024 -1.36 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 -4.29 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 -270,000.00
Jun 30, 2023 -1.02 Mn
Mar 31, 2023 -3.69 Mn
Dec 31, 2022 -3.70 Mn
Sep 30, 2022 2.60 Mn
Jun 30, 2022 606,000.00
Mar 31, 2022 1.72 Mn
Dec 31, 2021 2.49 Mn